H.C. Wainwright lifts ObsEva SA [OBSV] price estimate. Who else is bullish?

ObsEva SA [NASDAQ: OBSV] loss -50.77% on the last trading session, reaching $0.08 price per share at the time. The company report on February 24, 2023 that ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange.

GENEVA, Switzerland – February 24, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced a strategic reorganization that will consolidate operations in Switzerland so as to preserve cash, focus resources towards the development of nolasiban, a novel, oral oxytocin receptor agonist to improve in vitro fertilization success rates, and manage its out-licensed programs. As part of the reorganization, the Company is downsizing its US-based Executive Management team and will similarly propose a reduced Board of Directors at the next Annual General Meeting. Additionally, ObsEva is retiring its convertible debt, is expecting to be delisted from Nasdaq, and intends to deregister from the US Securities and Exchange Commission (“SEC”), while maintaining its current listing on SIX Swiss Exchange.

ObsEva SA represents 104.02 million in outstanding shares, while the company has a total market value of $17.50 million with the latest information. OBSV stock price has been found in the range of $0.08 to $0.1291.

If compared to the average trading volume of 854.28K shares, OBSV reached a trading volume of 19062634 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about ObsEva SA [OBSV]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OBSV shares is $6.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OBSV stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for ObsEva SA shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 30, 2022. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on June 03, 2022, representing the official price target for ObsEva SA stock. Previously, the target price had yet another raise to $12, while Canaccord Genuity analysts kept a Buy rating on OBSV stock.

The Average True Range (ATR) for ObsEva SA is set at 0.02, with the Price to Sales ratio for OBSV stock in the period of the last 12 months amounting to 2.03.

Trading performance analysis for OBSV stock

ObsEva SA [OBSV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -56.99. With this latest performance, OBSV shares dropped by -57.17% in over the last four-week period, additionally sinking by -61.36% over the last 6 months – not to mention a drop of -93.76% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OBSV stock in for the last two-week period is set at 15.28, with the RSI for the last a single of trading hit 8.50, and the three-weeks RSI is set at 21.93 for ObsEva SA [OBSV]. The present Moving Average for the last 50 days of trading for this stock 0.1787, while it was recorded at 0.1567 for the last single week of trading, and 0.5989 for the last 200 days.

ObsEva SA [OBSV]: A deeper dive into fundamental analysis

Return on Equity for this stock declined to -286.91, with Return on Assets sitting at -75.60.

ObsEva SA’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.60.

An analysis of insider ownership at ObsEva SA [OBSV]

There are presently around $1 million, or 14.30% of OBSV stock, in the hands of institutional investors. The top three institutional holders of OBSV stocks are: SOFINNOVA INVESTMENTS, INC. with ownership of 4,749,623, which is approximately 0% of the company’s market cap and around 2.02% of the total institutional ownership; NEA MANAGEMENT COMPANY, LLC, holding 4,586,563 shares of the stock with an approximate value of $0.38 million in OBSV stocks shares; and CREDIT SUISSE AG/, currently with $0.14 million in OBSV stock with ownership of nearly 10.998% of the company’s market capitalization.

Positions in ObsEva SA stocks held by institutional investors increased at the end of Thursday and at the time of the Thursday reporting period, where 7 institutional holders increased their position in ObsEva SA [NASDAQ:OBSV] by around 298,331 shares. Additionally, 16 investors decreased positions by around 946,026 shares, while 13 investors held positions by with 11,769,407 shares. The mentioned changes placed institutional holdings at 13,013,764 shares, according to the latest SEC report filing. OBSV stock had 2 new institutional investments in for a total of 71,788 shares, while 9 institutional investors sold positions of 718,590 shares during the same period.


Please enter your comment!
Please enter your name here